Skip to main content
. Author manuscript; available in PMC: 2020 Jul 17.
Published in final edited form as: Hepatoma Res. 2020 Jun 18;6:35. doi: 10.20517/2394-5079.2020.16

Table 1.

NAFLD-associated HCC epidemiology and burden

Country Incidence and prevalence Population Study period Ref.
United States 0.21 per 1000 person-years Veterans Affairs 2003-2011 Kanwal et al.[22]
14.1% of all cases SEER registries 2004-2009 Younossi et al.[136]
8% of all HCC cases Veterans Affairs 2005-2011 Mittal et al.[23]
1.56% of HCC cases Veterans Affairs 2012-2018 Ioannou et al.[24]
5.29 per 1000 person-years Meta-analysis 1989-2015 Younossi et al.[3]
13.5% of all liver transplants United Network Organ for Sharing 2000-2012 Wong et al.[26]
Spain, Italy, the Netherlands, United Kingdom 0.3 per 1000 person-years European primary care databases 2016 Alexander et al.[30]
United Kingdom 35% of all HCC referrals National Health Services 2010 Dyson et al.[137]
Japan 6% incidence Single hospital in Tokyo 1994-2007 Arase et al.[138]
South Korea 12.2% incidence South Korean hospital 2006-2010 Cho et al.[34]

NAFLD: nonalcoholic fatty liver disease; HCC: hepatocellular carcinoma; SEER: surveillance, epidemiology and end results